Loading...
Drug Development in Abu Dhabi: Advancing Innovation Through Government Support and a Thriving Ecosystem
Shaaban, Namir Saleh, Saleh Ibrahim Alameri, Mohamed Salem Hashmi, Sharukh Abu Nadia, Tareq
Shaaban, Namir
Saleh, Saleh Ibrahim
Alameri, Mohamed Salem
Hashmi, Sharukh
Abu Nadia, Tareq
Supervisor
Department
Computer Vision
Embargo End Date
Type
Journal article
Date
2025
License
Language
English
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Drug development is a complex, high-risk, and resource-intensive process, with global challenges such as high costs, regulatory hurdles, and low clinical trial success rates. These obstacles are especially acute for biotech startups and companies in emerging markets, where access to infrastructure, patient populations, and capital can be limited. This Perspective advocates for Abu Dhabi’s emerging life sciences ecosystem as a potential framework for other regions seeking to accelerate pharmaceutical innovation. By offering government-backed incentives, advanced research infrastructure, regulatory support, and access to regional genomic data, Abu Dhabi provides a model for addressing industry bottlenecks and fostering sustainable drug development growth in new markets.
Citation
“Drug Development in Abu Dhabi: Advancing Innovation Through Government Support and a Thriving Ecosystem.” [Online]. Available: https://www.cellphysiolbiochem.com/Articles/000794/
Source
Cellular Physiology & Biochemistry
Conference
Keywords
Subjects
Source
Publisher
Cell Physiol Biochem Press